quinazolines has been researched along with Endotoxin Shock in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdulkhalek, S; Bandyopadhyay, SK; Chattopadhyay, S; Fensterl, V; Poddar, D; Sen, GC; Veleeparambil, M | 1 |
| Banerjee, S; Bose, D; Chatterjee, N; Chattopadhyay, D; Das, S; Saha, KD | 1 |
| Esmaili, A; Vahid, B | 1 |
| Bateman-Fite, R; Brackeen, MF; Clark, RL; Connolly, KM; Menius, JA; Noel, LS; Sekut, L; Stimpson, SA; Yarnall, D | 1 |
| Bierwagen, ME; Buyniski, JP; Cavanagh, RL; Fleming, JS | 1 |
5 other study(ies) available for quinazolines and Endotoxin Shock
| Article | Year |
|---|---|
EGFR kinase activity is required for TLR4 signaling and the septic shock response.
Topics: Animals; ErbB Receptors; Gefitinib; Interferon Regulatory Factors; Interferon-beta; Lipopolysaccharides; Mice; Microarray Analysis; Myeloid Cells; NF-kappa B; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Quinazolines; RAW 264.7 Cells; Shock, Septic; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2015 |
Exploring the anti-inflammatory activity of a novel 2-phenylquinazoline analog with protection against inflammatory injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Capillary Permeability; Carrageenan; Cell Line; Cell Survival; Cytokines; Dinoprostone; Female; Formaldehyde; Inflammation; Lipopolysaccharides; Liver; Liver Function Tests; Macrophages; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; NF-kappa B; Nitric Oxide; Quinazolines; Shock, Septic; Survival | 2012 |
Erlotinib-associated acute pneumonitis: report of two cases.
Topics: Acute Disease; Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Fatal Outcome; Female; Glucocorticoids; Humans; Lung Neoplasms; Male; Methylprednisolone; Middle Aged; Pneumonia; Protein Kinase Inhibitors; Quinazolines; Shock, Septic | 2007 |
Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Female; Galactosamine; Inflammation; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Purinones; Pyridazines; Pyrrolidinones; Quinazolines; Rats; Rats, Inbred Lew; Rolipram; Shock, Septic; Tumor Necrosis Factor-alpha | 1995 |
Pharmacology of a potent, new antithrombotic agent, 6-methyl-1,2,3,5-tetrahydroimidazo[2, 1-b] quinazolin-2-one hydrochloride monohydrate.
Topics: Animals; Carotid Arteries; Dogs; Fibrinolytic Agents; Guinea Pigs; Hemodynamics; Imidazoles; In Vitro Techniques; Lasers; Muscle, Smooth; Platelet Aggregation; Quinazolines; Rabbits; Rats; Serotonin; Shock, Hemorrhagic; Shock, Septic; Thrombosis | 1975 |